malignant gliomas
Showing 1 - 25 of 4,459
Mapping of Tumor Stem Cells in Resection Marigin During
Recruiting
- Glioma, Malignant
- GlioStem
-
Stockholm, SwedenKarolinska University Hospital
Sep 22, 2022
Clinical Development of Cancer-Specific MRS Biomarkers in
Completed
- Malignant Gliomas
- +2 more
- 3 Tesla scanning
-
Dallas, TexasUT Southwestern Medical Center
Jan 19, 2022
Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)
Active, not recruiting
- Brain Tumor, Recurrent
- +4 more
- Cytoreductive surgery
- +2 more
-
New York, New York
- +1 more
Jun 9, 2022
Malignant Glioma, Anxiety, Caregiver Burden Trial in Boston (Psychosocial Intervention Group, Usual Care Group)
Active, not recruiting
- Malignant Glioma
- +3 more
- Psychosocial Intervention Group
- Usual Care Group
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jul 12, 2022
Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)
Terminated
- Brain and Central Nervous System Tumors
- thalidomide
- topotecan hydrochloride
-
Chicago, IllinoisRush Cancer Institute at Rush University Medical Center
Jan 5, 2023
Glioma, Malignant Trial in Bangkok (ERC1671, GM-CSF, Cyclophosphamide)
Not yet recruiting
- Glioma, Malignant
- ERC1671
- +3 more
-
Bangkok, Vadhana, ThailandBumrungrad International Hospital
May 9, 2022
Malignant Glioma Trial in Paris (Surgery, radiotherapy)
Completed
- Malignant Glioma
- Surgery
- radiotherapy
-
Paris, FranceFlorence Laigle
Nov 26, 2021
Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)
Active, not recruiting
- Glioblastoma
- +3 more
- Stereotactic Radiosurgery
-
Lake Success, New YorkNorthwell Health Brain Tumor Center
Feb 3, 2022
5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for
Not yet recruiting
- High Grade Glioma
- +10 more
- 5-Aminolevulinic Acid (5-ALA) Gliolan®
- Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 28, 2023
Social Cognition and Language in Patients With Gliomas
Not yet recruiting
- Glioma, Malignant
- Cognitive Dysfunction
- Neuropsychological tests
- (no location specified)
Mar 9, 2023
Gliomas Using a Broad Next Generation Sequencing (NGS)Panel
Completed
- Malignant Glioma
- (no location specified)
Aug 2, 2022
Brain Cancer, Glioma Trial in New York (MRI and advanced MRI sequences)
Recruiting
- Brain Cancer
- Glioma
- MRI and advanced MRI sequences
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 1, 2021
Glioma, Malignant, Computer-Assisted Trial in Shanghai (Validation of IDH1 mutations from the radiomics model)
Active, not recruiting
- Glioma, Malignant
- Computer-Assisted
- Validation of IDH1 mutations from the radiomics model
-
Shanghai, Shanghai, ChinaHuashan Hospital, Fudan University
Jul 23, 2023
Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)
Recruiting
- Glioma
- +4 more
- 3T MRI scanner
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Clinical Development of MR Spectroscopy and Imaging in Brain
Completed
- Malignant Gliomas
- +2 more
- 3 Tesla Scanning
- 7 Tesla Scanning
-
Dallas, TexasUT Southwestern Medical Center
Jan 19, 2022
Glioma, Malignant Glioma of Brain, Recurrence Tumor Trial in Beijing (chimeric antigen receptor T cells)
Recruiting
- Glioma
- +2 more
- chimeric antigen receptor T cells
-
Beijing, ChinaXuanwu Hospital
Jun 12, 2021
Gliomas Benign, Glioma, Malignant, Metastases to Brain Trial (Tumor resection in awake patient, Tumor resection in asleep
Not yet recruiting
- Gliomas Benign
- +2 more
- Tumor resection in awake patient
- Tumor resection in asleep patient
- (no location specified)
Jul 30, 2022
Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)
Recruiting
- Brain Gliomas
- Allogenic B7H3 CAR-γδT cell
-
Suzhou, Jiangsu, ChinaDushu Lake Hospital Affiliated to Soochow University
Aug 25, 2023
Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant Trial in Saint Louis (temporally-modulated pulsed radiotherapy (TMPRT))
Recruiting
- Astrocytoma
- +2 more
- temporally-modulated pulsed radiotherapy (TMPRT)
-
Saint Louis, MissouriWashington University School of Medicine
Jan 19, 2023
Low-grade Glioma, IDH2 Gene Mutation, Recurrent Glioma Trial in Boston (Niraparib, Resection/Treatment with Niraparib)
Recruiting
- Low-grade Glioma
- +4 more
- Niraparib
- Resection/Treatment with Niraparib
-
Boston, MassachusettsMassachusetts General Hospital
Oct 19, 2022
Gliomas, Malignant, Metastases to Brain Trial in Moscow (Ultrasound guided brain tumor resection, 5-aminolevulinic acid
Not yet recruiting
- Gliomas, Malignant
- Metastases to Brain
- Ultrasound guided brain tumor resection
- 5-aminolevulinic acid fluorescence-guided brain tumor resection
-
Moscow, Russian FederationSklifosovsky Institute of Emergency Care
Jul 26, 2022
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
Glioma, Malignant, Metastases to Brain Trial (Combined ultrasound and fluorescence-guided brain tumor resection,
Not yet recruiting
- Glioma, Malignant
- Metastases to Brain
- Combined ultrasound and fluorescence-guided brain tumor resection
- Fluorescence-guided brain tumor resection
- (no location specified)
Jul 28, 2022
Malignant Glioma Trial in Rochester (Fluorine-18-L-dihydroxyphenylalanine)
Active, not recruiting
- Malignant Glioma
-
Rochester, MinnesotaMayo Clinic
Oct 10, 2022
Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,
Recruiting
- Malignant Glioma
- High Grade Glioma
- TTRNA-DC vaccines with GM-CSF
- +4 more
-
Birmingham, Alabama
- +2 more
Feb 2, 2023